I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site

ACTRIMS Forum 2026

We will be contributing to topics related to
-
01:45 AM
Duration 105mins San Diego, USA
Long-Term Impact on Work Productivity and Cognition With First-Line Ocrelizumab Treatment
Craveiro, Licinio; Benedict H. B., Ralph; Berger, Thomas; Bermel A., Robert; Vanopdenbosch, Ludo; Holmøy, Trygve; Clinch, Susanne; Moore, Suzanne; Killestein, Joep
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 105mins San Diego, USA
Ocrelizumab Reduces the Risk of Progression Independent of Relapses (PIRA): An Analysis of the Phase III OPERA Trials Using Multiple PIRA Definitions
Craveiro, Licinio; Bermel, Robert A; Lorscheider, Johannes; Butzkueven, Helmut; Wang, Qing; Jones, David; Cutter, Gary; Kappos, Ludwig
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 105mins San Diego, USA
Association of Composite Confirmed Disability Progression With Clinical, Biomarker and Patient-Reported Outcomes
Brownlee, Wallace; Bermel A., Robert; Ghazaleh, Naghmeh; Abdul Samad, Jad; Wang, Qing; Bonati, Ulrike; Tumani, Hayrettin; Kappos, Ludwig
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 105mins San Diego, USA
Delay in Progression to Key Disability Milestones With Ocrelizumab in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO-HAND Study
Oh, Jiwon; Giovannoni, Gavin; Airas, Laura; Bove, Riley; Cutter, R., Gary; Hobart, Jeremy; Kuhle, Jens; Montalban, Xavier; Tur, Carmen; Wolinsky, S., Jerry; Schneble, Hans-Martin; Baldinotti, Anna; Bonati, Ulrike; Giacobino, Caroline; Wang, Qing; Craveiro, Licinio
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 105mins San Diego, USA
No Evidence of Disease Activity (NEDA-3) in Treatment-Naive People With Relapsing Multiple Sclerosis Treated With Intravenous or Subcutaneous Ocrelizumab: Findings of the OPERA (10 Years) and OCARINA II (2 Years) Studies
Cree, Bruce A. C; Newsome, Scott D., Cerqueira, João; Centonze, Diego; Traboulsee, Anthony; Craveiro, Licinio; Schenble, Hans-Martin; Zecevic, Dusanka; Figueirido, Catarina; Wang, Qing; Giacobino, Caroline; Selmaj, Krzysztof
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 105mins San Diego, USA
Intravenous and Subcutaneous Ocrelizumab Lead to Sustained Reductions in Serum Neurofilament Light Chain Levels in Treatment-Naive People With Multiple Sclerosis
Bar-Or, Amit; Krzystanek, Ewa; Kuhle, Jens; Monreal, Enric; Selmaj, Krzysztof; Craveiro, Licinio; Figueiredo, Catarina; Giacobino, Caroline; Raposo, Catarina; Shen, Yun-An; Thanei, Gian-Andrea; Newsome, Scott D
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 105mins San Diego, USA
Exploring the Potential of Combination Therapy to Tackle MS Progression: Design of the Phase II MINTAKA Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of the Oral Monoacylglycerol Lipase Inhibitor RG6182 as an Add-On to Ocrelizumab in People With Progressive Multiple Sclerosis
Overell, James; Krumova, Petranka; Sturm, Stefan; Hubeaux, Stanislas; Magon, Stefano; Mandic, Iva; Cottreel, Emmanuelle; Portron, Agnes; Yu, Huixin; Poirier, Agnes; Hayward-Koennecke, Helen; Stroband Majid, Homa; Collin, Ludovic; Baker, Mike; Schippling, Sven; Stephan, Alexander
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:45 AM
Duration 105mins San Diego, USA
Real-World Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: Insights From the MSOCR-P Cohort, a MSBase Registry Sub-Study
Craveiro, Licinio; Butzkueven, Helmut; Farr, Pamela; Ozakbas, Serkan; Laureys, Guy; Alroughani, Raed; Horakova, Dana; Rous, Zuzana; Houskova, Jana; van der Walt, Anneke; Brecl Jakob, Gregor; Kalincik, Tomas; Hradilek, Pavel; Meca-Lallana, Jose E.; Boz, Cavit; Lechner-Scott, Jeanette; Sanchez-Menoyo, Jose Luis; Buzzard, Katherine; Willekens, Barbara; Grand'Maison, Francois; Cartechini, Elisabetta; Habek, Mario; Recmanova, Eva; Yetkin, Mehmet Fatih; Stourac, Pavel; Muros-Le Rouzic, Erwan; Spelman, Tim; MSBase Investigators
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 105mins San Diego, USA
Real-World Effectiveness of First-Line Ocrelizumab Treatment in Relapsing Multiple Sclerosis: Insights From the MSBase OCR-R Sub-Study
Craveiro, Licinio; Butzkueven, Helmut; Farr, Pamela; Alroughani, Raed; Van Der Walt, Anneke; Kalincik, Tomas; Kermode, Allan; Lechner-Scott, Jeanette; Foschi, Mateo; Boz, Cavit; Ozakbas, Serkan; Buzzard, Katherine; Skibina, Olga; Grand'Maison, Francois; Rojas, Juan; Laureys, Guy; Ramo-Tello, Cristina; Barnett, Michael; Besora, Sarah; Willekens, Barbara; Muros-Le Rouzic, Erwan; Spelman, Tim; MSBase Investigators
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 105mins San Diego, USA
Safety of Ocrelizumab vs Other Disease-Modifying Therapies in People With Relapsing Multiple Sclerosis Aged 55 Years or Older
Craveiro, Licinio; Butzkueven, Helmut; Buttman, Mathias; Duran-Pacheco, Gonzalo Christian; El Azouzzi, Bouchra; Elberling, Frederik; Ferreira, Germano; Flavia Mouresan, Elena; Glaser, Anna; Hillert, Jan; Iaffaldano, Pietro; Lucisano, Giuseppe; Muros-Le Rouzic, Erwan; Rollot, Fabien; Trojano, Maria; Vukusic, Sandra; Zhu, Chao; Ziemssen, Tjalf; Magyari, Melinda
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:27 PM
Duration 13mins San Diego, USA
Efficacy and Safety of Fenebrutinib vs Ocrelizumab in Primary Progressive Multiple Sclerosis: Primary Results of the Phase III FENtrepid Study
Bar-Or, Amit; Oh, Jiwon; Giovannoni, Gavin; Sormani, Maria Pia; Weber, Martin S; Stoll, Sharon; Nicholas, Jacqueline A; von Büdingen, H.-Christian; Lopez, Jon; Roberts, Louise; Triyatni, Miriam; Qi, Qi; Ratchford, Jack; Napieralski, Julie; Goodyear, Alexandra; Hauser, Stephen L; Kappos, Ludwig
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon